In this study we investigated the role of endogenous endothelin in the cardiovascular response to acute stress, ie mild footshocks in conscious rats. Footshockstress significantly increased mean arterial pressure and heart rate (P Ͻ 0.05). Peripheral or intracerebroventricular (IVT) administration of BQ 788, a selective antagonist of ET B receptor, did not alter pressor response to footshocks. Intraperitoneal injections of BQ 123 (1 mg/kg), a selective antagonist of the ET A -receptor, had a tendency to decrease, while BQ 123
Introduction
Endothelin (ET) belongs to a family of vasoactive peptides originally isolated from the supernatant of cultured porcine aortic endothelial cells. 1 In addition to its systemic vascular effects, a number of reports indicate that ETs may also act on the central nervous system as a neurotransmitter or neuromodulator. 2 Indeed, ET immunoreactivity of non-vascular origin and neural localisation within the brain has been demonstrated by immunohistochemistry; Northern blot analysis and in situ hybridisation techniques. 3, 4 In addition, it has been shown the presence of ET receptors in localised areas of the central nervous system. [4] [5] [6] Several lines of evidence support the view that central endothelin may play an important role in the sympathetic activity and cardiovascular regulation. A large density of ET-containing neurons, 3, 4 ET receptors 7 and localisation of ET-converting enzyme activity 8 have been identified in areas actively involved in the sympathetic nerve activity and cardiovascular control, including specific nuclei of the hypothalamus such as the supraoptic and paraventricular nuclei, and brain structures known to alter sympathetic outflow such as the nucleus tractus solitarius (NTS), the rostral ventrolateral medulla (RVLM) and several circumventricular organs.
It has been shown that ETs can trigger selected cardiovascular effects when administered intracisternally, 9 ,10 into cerebral ventricles, 11, 12 or into brain areas such as NTS 13 and subfornical organ, 14 sug-gesting that ET may participate in the cardiovascular and sympathetic activity regulation through the central nervous system. Thus, it is plausible to hypothesise that alterations in the central endothelinergic system would result in increases of sympathetic outflow and blood pressure. The hypothalamic-pituitary-adrenocortical (HPA) axis and the autonomic nervous system are major effector systems that serve to maintain homeostasis during exposure to stressors. The neuroanatomical basis for the activation of the HPA axis by any given stressor has not been fully characterised, but interest in neurochemical regulation and pathways controlling activation of the HPA axis has focused on catecholamines. Stress is thought to contribute to the development of hypertension. It is generally accepted that stress-induced hypertension is due to increases in sympathoadrenal activity, catecholamines release and enhanced vascular tone. 15 Several stress paradigms have been used to study the effects of stress on the cardiovascular system, among them, chronic cold stress and cold water pressor test has been shown to produce hypertension in rats. This effect could be mediated by several mechanisms such as sympathetic activation, release of vasopressin, release of central catecholamines, or by a combination of some of them.
No direct evidence for an involvement of central endothelin in the sympathetic response to stress has been presented so far. In addition, there is no clear knowledge about the interaction of endothelins with neuronal transmission during stress. We investigated the role of endothelin receptor subtypes in the vasopressor response to footshocks, an experimental model known to increase sympathoadrenal activity, assessing the effect of central or peripheral administration of ET A and ET B receptor selective antagonists, in conscious unrestrained rats.
Materials and methods
Normotensive male Sprague-Dawley rats (180-230 g) were obtained from an established colony at the School of Pharmacy, Universidad Central de Venezuela. The rats were provided with standard rat food and water ad libitum and were housed under controlled conditions of temperature and photoperiod (light on from 06.00 to 18.00). A group of rats was implanted with a cannula in the left lateral cerebroventricle, 16 1 mm caudal to the coronal suture and 1.5 mm lateral to the midsagittal suture, with the aid of a stereotaxic instrument and under pentobarbital anesthesia (40 mg/kg, i.p.). A minimum of 3 days was allowed for recovery. Single intracerebroventricular (IVT) injections were made with a Hamilton syringe fitted with a stop to prevent the needle penetration past the cannula tip. Ventricular cannula placement was confirmed postmortem by examining the distribution of an IVT injection of 5 l of fast green dye, given before the animal was killed. Data were used only if the dye was distributed in the four ventricles.
Quantification of cardiovascular responses to footshocks
Blood pressure was measured by the tail-cuff method. 17 Systolic and diastolic pressure and heart rate were recorded using a tail-cuff digital plethysmograph (LE 5000, LETICA Scientific Instruments, Barcelona, Spain). After drug treatment, the animals were transferred to a plexiglass chamber with a copper rod floor, where they received mild footshocks (2.0 Hz, 100V, 5 ms, 5 min) delivered by a Grass stimulator (Model S48). The rats were placed into the heating oven and after 10 min of heating, footshock-stimulation was performed inside the oven for a period of 5 min. Immediately after this procedure, measurements of the cardiovascular parameters were taken. Basal mean arterial tail-cuff pressure (MAP) and heart rate (HR) were determined before drug treatment and 5 min before footshocks. The MAP and the HR determined immediately before footshocks were considered as basal.
In order to establish the effect of endothelinergic drugs on stress-induced increases in blood pressure and heart rate, rats were randomly distributed into the following groups: pretreated with saline, BQ 123 (1 mg/kg, i.p., 30 min before), BQ 788 (1 mg/kg, i.p., 30 min before). Another group of rats were implanted with an IVT-cannula and randomly distributed into the following groups (all IVT injected): control (saline, 5 l); BQ 123 (203 ng/5 l); BQ 788 (381 ng/5 l). After treatment, the animals were subjected to mild inescapable footshocks (2.0 Hz, 100 V, 5 ms, 5 min) as described previously. 17 The response was recorded 30 min after administration of the ET receptors blockers. All data were expressed as mean MAP ± s.e.m. and calculated as the sum of diastolic blood pressure plus one-third the pulse pressure in mm Hg, and heart rate in beats per minute.
Statistics
Data are presented as the means ± s.e.m. Statistical differences between groups were evaluated by Student's t-test or one-way analysis of variance (ANOVA) and pairwise comparisons using the Bonferroni test. A value of P Ͻ 0.05 was considered significant.
Results
Effect of ET A or ET B receptor antagonist on basal MAP and HR and on the pressor response to footshocks. Table 1 
Discussion
Several lines of evidence indicate that brain endothelins may play an important role in the regulation of sympathetic outflow and blood pressure. Indeed, intracerebroventricular injections of ET-1 consistently elevate systemic arterial blood pressure in rats and this rise occurs mainly as a consequence of augmented sympathetic nerve activity because the pressor effect was reported to be accompanied by an increase in renal sympathetic nerve activity and plasma levels of catecholamines and arginine vasopressin. 11, 18, 19 Furthermore, the greater increase in plasma adrenaline than that of noradrenaline concentrations after central administration of endothelin suggests that the adrenal medulla may be important as the source of catecholamines. 20 The cardiovascular effect of intracisternally administration of ET on mean arterial pressure is mainly attributed to changes in sympathetic outflow and stimulation of alpha-adrenoreceptors, since the ETinduced responses were attenuated by pretreatment with intravenous phenoxybenzamine 20 and ganglion blockers 21 but not with antagonists for angiotensin II or vasopressin V1 receptors. 9, 21 The role of brain ET and their receptors subtypes on the sympathetic outflow is not clear, and no direct evidence for an involvement of central ET receptors in the sympathetic response to stress has been presented so far. ET binding sites are identified in central nervous system areas critically involved in the central neural control of the circulation and respiration. 9 These include hypothalamic nuclei, nucleus tractus solitarious (NTS), the dorsal motor nucleus of the vagus (DMNV), and the rostral vetrolateral medulla (RVLM), all of which play an important role in the central mechanisms of sympathetic outflow control. In general, the brain appears to contain predominantly, if not exclusively, endothelin ET B receptors. However, using a Journal of Human Hypertension specific antibody against ET A receptor 22 it was found it to be widely distributed on cell bodies and neuron terminals in several parts of the rat brain, including a number of medullary regions, the arcuate nucleus of the hypothalamus, ventral tegmental area and in the locus coeruleus, an area rich in noradrenergic neurons, which are known to be activated by physiological challenges and stimuli that are considered stressors.
It has been shown that the sympathetic and cardiovascular effects of centrally injected ET-1 were inhibited by BQ123, but not by RES701-1, an ET B1 antagonist, which points to the involvement of ET A receptors in the central effects of exogenous ET-1. 19 Furthermore, it has been reported that ET-1 administered into the RVLM alter the firing pattern of vasomotor neurons and this effects were inhibited by BQ123, but were unaffected by BQ788. 23 The fact that neither the ET A nor the ET B antagonists per se, affected basal levels of the cardiovascular parameters argues against the possibility that ET tonically regulates sympathetic and cardiovascular activities in the central nervous system of normotensive rats (reference 19, present results); however its possible that central ET might tonically activate sympathetic nerve activity, thereby contributing to blood pressure elevation in a model of hypertension like SHR-SP, were the ET A receptor antagonist per se decreased sympathetic nerve activity, blood pressure and heart rate. 19 Likewise, since stress is thought to be associated with elevated arterial pressure due to increased sympathetic nerve activity, 15 it is conceivable that during sympathetic stimulation induced by stress, endogenous ET may play an important role in the modulation of sympathetic outflow through the stimulation of specific receptors. A potential regulatory effect of endogenous brain endothelin on sympathetic activity during stress is suggested by our results in which we demonstrated that after enhancement of sympathetic activity with mild inescapable footshocks presented to conscious rats, central blockade of ET A receptor with BQ123, but not with BQ788, results in a decreased pressor response to footshocks, ie inhibition of sympathetic activity inasmuch as this pressor response was almost completely abolished by alpha-adrenergic blocker phentolamine.
Cathecholamines also play an important role in maintaining the vascular tone. Several in vitro evi-dence points to the possibility of an involvement of endothelin in the development of hypertension during acute and chronic stress through the interaction with neuronal transmission in peripheral tissues. Addition of endothelin-1 reduced noradrenaline release from sympathetic nerve endings in guinea pig femoral and pulmonary artery, 24, 25 dog renal artery 26 and rat mesenteric artery. 27 In contrast, sympathetic transmission was enhanced by endothelin in rabbit ear artery, 28 rat tail artery 29 and dog adrenal. 30 These differences in results could possibly be explained by the experimental conditions: low or high stimulus frequencies 29 or by dose-dependency, since it was demonstrated that, in rat tail artery, low doses of endothelins reduced stimulus-evoked noradrenaline release, whereas higher doses decreased it. These actions were mediated by ET B receptors since they were blocked by BQ 788. 31 It is conceivable that ET may also modulate presynaptically the noradrenaline release from nerve terminals during sympathetic stimulation in vivo; thus, it should be expected that blockade of ET receptors would prevent the modulatory (facilitatory or inhibitory) action of endogenous endothelin on noradreline release from nerve terminals which would result in an altered (increase or decrease) haemodynamic response to footshocks. Our results show that peripheral blockade of either ET A or ET B receptor does not cause any effect on the pressor response to footshocks as it does occur by IVT administration. Therefore, the BQ123 inhibitory effect on pressor response to footshocks is central in location.
In summary, our results sustain the hypothesis that, although central endothelin might not have a tonic stimulatory effect on sympathetic and cardiovascular system in normotensive rats, central ET may participate in the activation of sympathetic nerve activity during stress, through the interaction with ET A receptors, thereby contributing to the blood pressure response to footshocks.
